The Novo-backed medical implant provider has filed to raise up to $97.8m in an initial public offering that comes after $103m in funding.
US-based medical device producer SI-Bone has filed for a $97.8m initial public offering on the Nasdaq Global Market that will give pharmaceutical firm Novo the chance of an exit.
SI-Bone has developed a surgical implant called iFuse that fuses the sacroiliac joint in order to combat joint dysfunction that can lead to intense lower back pain. It launched the second iteration of the system, the iFuse-3D, in 2017.
The company increased its revenue for the first half of the…
